HUTCHMED (China) Limited - ADR

+1.35 (+3.60%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.72B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$94.82 Million
Adjusted EPS-$0.24
See more estimates
10-Day MA$39.03
50-Day MA$39.89
200-Day MA$32.81
See more pivots

HUTCHMED (China) Limited - ADR Stock, NASDAQ:HCM

Cheung Kong Center, 2 Queen's Road Central, Hong Kong, Central & Western
Cayman Islands
Phone: +852.2121.8200
Number of Employees: 1280


Hutchmed (China) Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment covers all activities related to oncology/immunology including sales, marketing, manufacturing and research and development with respect to drugs and drug candidates. The Other Ventures segment includes all other Hutchmed businesses. The company was founded in June 2000 and is headquartered in Hong Kong.